

Aramis Biosciences Information
Contact top employees from
Aramis Biosciences
Summary
Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease....Show more
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Founded
2018
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
2014 | Public Company | 25 - 100 | < 1M | $293M | |
2015 | Privately Held | 10-50 | < 1M | $1M | |
2015 | Privately Held | 1 - 25 | < 1M | $0 | |
2018 | - | 100-200 | - | $- | |
2020 | - | 1-10 | - | $- | |
- | - | 1-10 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Aramis Biosciences shows a diverse range of experience levels:
20% for 1–2 years40% for 3–4 years40% for 5–7 yearsContact top employees from
Aramis Biosciences
David Tierney
President & CEO
David Lacey
Chief Operating Officer
Similar Companies
FAQ
Aramis Biosciences operates in the Biotechnology industries. More details can be found on the official website: aramisbio.com.
The headquarters of Aramis Biosciences are located in Boston, United States.
Aramis Biosciences currently employs 1-10 people.
Well-known competitors of Aramis Biosciences include Aro Biotherapeutics, ORIC Pharmaceuticals Inc., Saol Therapeutics and Context Therapeutics.